Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DRUG EVALUATION AND DECISION MAKING IN CATALONIA: DEVELOPMENT AND VALIDATION OF A METHODOLOGICAL FRAMEWORK BASED ON MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR ORPHAN DRUGS.
Gilabert-Perramon A, Torrent-Farnell J, Catalan A, Prat A, Fontanet M, Puig-Peiró R, Merino-Montero S, Khoury H, Goetghebeur MM, Badia X. Gilabert-Perramon A, et al. Among authors: badia x. Int J Technol Assess Health Care. 2017 Jan;33(1):111-120. doi: 10.1017/S0266462317000149. Epub 2017 Apr 24. Int J Technol Assess Health Care. 2017. PMID: 28434413
MULTI-CRITERIA DECISION ANALYSIS AS A DECISION-SUPPORT TOOL FOR DRUG EVALUATION: A PILOT STUDY IN A PHARMACY AND THERAPEUTICS COMMITTEE SETTING.
Roldán ÚB, Badia X, Marcos-Rodríguez JA, de la Cruz-Merino L, Gómez-González J, Melcón-de Dios A, Caraballo-Camacho MO, Cordero-Ramos J, Alvarado-Fernández MD, Galiana-Auchel JM, Calleja-Hernández MÁ. Roldán ÚB, et al. Among authors: badia x. Int J Technol Assess Health Care. 2018 Jan;34(5):519-526. doi: 10.1017/S0266462318000569. Epub 2018 Oct 23. Int J Technol Assess Health Care. 2018. PMID: 30348241
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia X, Calleja MÁ, Escudero-Vilaplana V, Pérez-Martínez A, Piñana JL, Poveda JL, Vallès JA. Badia X, et al. Orphanet J Rare Dis. 2024 Aug 23;19(1):308. doi: 10.1186/s13023-024-03324-5. Orphanet J Rare Dis. 2024. PMID: 39180132 Free PMC article.
202 results